Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service
Conclusions:
CI can provide significant and sustained auditory benefits to patients with NF2 independent of tumor treatment modality, with the majority of those implanted becoming at least part-time users. Larger datasets are required to reliably assess the role of independent variables.
Source: Otology and Neurotology - Category: ENT & OMF Tags: COCHLEAR IMPLANTS Source Type: research
More News: Audiology | Audiometry | Brain | ENT & OMF | Neurofibromatosis | Neurology | Neurosurgery | New York University | Rehabilitation | Study | UK Health